TCM
PFE icon

Traynor Capital Management’s Pfizer PFE Stock Holding History

Traynor Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,000
Closed -$498K – 263
2023
Q3 		$498K Buy
+15,000
New +$530K 0.06% 127
2023
Q2 		– Sell
-15,000
Closed -$612K – 234
2023
Q1 		$612K Hold
15,000
– – 0.09% 114
2022
Q4 		$769K Buy
+15,000
New +$719K 0.11% 101

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Traynor Capital Management's PFE Position: Q2 2026 in Review

Traynor Capital Management increased its Pfizer (PFE) stake by 8.1% in Q2 2026, buying an estimated $37.7K and bringing the position to 19,204 shares worth $462K. The position accounts for 0.02% of the portfolio, ranked #206.

Traynor Capital Management first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $7.22M in Q4 2021. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Traynor Capital Management held 19,204 shares of Pfizer worth $462K as of Q2 2026.
  • Traynor Capital Management bought 1,443 Pfizer shares in Q2 2026, an estimated $37.7K.
  • Pfizer made up 0.02% of Traynor Capital Management's portfolio in Q2 2026, its #206 holding.
  • Traynor Capital Management first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
  • Traynor Capital Management's Pfizer position peaked at $7.22M in Q4 2021.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.